Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Oligodendroglioma × Busulfan × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 68 Leukemia 56 Myelodysplastic Syndromes 53 Lymphoma 47 Precursor Cell Lymphoblastic Leukemia-Lymphoma 46 Lymphoma, Non-Hodgkin 43 Multiple Myeloma 40 Hodgkin Disease 39 Leukemia, Lymphocytic, Chronic, B-Cell 35 Congenital Abnormalities 30 Lymphoma, Follicular 28 Lymphoma, Large B-Cell, Diffuse 27 Lymphoma, Mantle-Cell 26 Neoplasms, Plasma Cell 25 Lymphoma, B-Cell, Marginal Zone 24 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 23 Burkitt Lymphoma 23 Myeloproliferative Disorders 22 Lymphoma, Large-Cell, Immunoblastic 22 Leukemia, Myelomonocytic, Chronic 22 Blast Crisis 22 Leukemia, Myeloid, Chronic-Phase 21 Leukemia, Myeloid, Accelerated Phase 21 Primary Myelofibrosis 19 Lymphoma, T-Cell, Cutaneous 15 Hematologic Neoplasms 15 Graft vs Host Disease 15 Dendritic Cell Sarcoma, Interdigitating 14 Anemia, Refractory, with Excess of Blasts 14 Waldenstrom Macroglobulinemia 13

Interventions

Temozolomide 14 Bevacizumab 11 Erlotinib Hydrochloride 5 Radiotherapy 4 Carboplatin 4 Magnetic Resonance Spectroscopy 3 Irinotecan 3 Immunoglobulin G 3 Disulfides 3 temsirolimus 2 poly ICLC 2 palbociclib 2 etoposide phosphate 2 antineoplaston AS 2-1 2 antineoplaston A10 2 Vincristine 2 Sunitinib 2 Sirolimus 2 Everolimus 2 Dasatinib 2 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2 veliparib 1 varlilumab 1 vandetanib 1 trebananib 1 trametinib 1 terameprocol 1 tandutinib 1 selinexor 1 romidepsin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡